Integrated bioinformatic and experimental study links cyclin B1/B2 to poor prognosis and immune infiltration in endometrial cancer
CCNB1 and CCNB2 may serve as potential prognostic markers and therapeutic targets for the management of EC.
Authors
- Lie Yu (ORCID: https://orcid.org/0009-0005-3666-7063)
- Ru Pan
- Dan Zheng (ORCID: https://orcid.org/0009-0007-6377-8177)
- Haochang Liu
- Haikun Yang
- Yaoxiang Zhong
- Lanlan Li (ORCID: https://orcid.org/0000-0002-7485-2017)
- Zhengping Zhang (ORCID: https://orcid.org/0000-0002-6113-3072)
Institutions
- Meizhou City People's Hospital (CN)
Publication Details
- Journal
- Journal of Obstetrics and Gynaecology
- Published
- 2025-09-13
- DOI
- https://doi.org/10.1080/01443615.2025.2551729
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00